Hypercytokinaemia accompanies HIV-tuberculosis immune reconstitution inflammatory syndrome.
Increased access to combination antiretroviral therapy in areas co-endemic for tuberculosis (TB) and HIV-1 infection is associated with an increased incidence of immune reconstitution inflammatory syndrome (TB-IRIS) whose cause is poorly understood. A case-control analysis of pro- and anti-inflammatory cytokines in TB-IRIS patients sampled at clinical presentation, and similar control patients with HIV-TB prescribed combined antiretroviral therapy who did not develop TB-IRIS. Peripheral blood mononuclear cells were cultured in the presence or absence of heat-killed Mycobacterium tuberculosis for 6 and 24 h. Stimulation with M. tuberculosis increased the abundance of many cytokine transcripts with interleukin (IL)-1β, IL-5, IL-6, IL-10, IL-13, IL-17A, interferon (IFN)-γ, granulocyte-macrophage colony-stimulating factor (GM-CSF) and tumour necrosis factor (TNF) being greater in stimulated TB-IRIS cultures. Analysis of the corresponding proteins in culture supernatants, revealed increased IL-1β, IL-2, IL-6, IL-8, IL-10, IL-12p40, IFN-γ, GM-CSF and TNF in TB-IRIS cultures. In serum, higher concentrations of TNF, IL-6, and IFN-γ were observed in TB-IRIS patients. Serum IL-6 and TNF decreased during prednisone therapy in TB-IRIS patients. These data suggest that cytokine release contributes to pathology in TB-IRIS. IL-6 and TNF were consistently elevated and decreased in serum during corticosteroid therapy. Specific blockade of these cytokines may be rational approach to immunomodulation in TB-IRIS.
Tadokera
R
R
Clinical Infectious Diseases Research Initiative, Institute of Infectious Diseases and Molecular Medicine, University of Cape Town, South Africa.
Meintjes
G
G
Skolimowska
K H
KH
Wilkinson
K A
KA
Matthews
K
K
Seldon
R
R
Chegou
N N
NN
Maartens
G
G
Rangaka
M X
MX
Rebe
K
K
Walzl
G
G
Wilkinson
R J
RJ
D000328:Adult; D023241:Antiretroviral Therapy, Highly Active / Q000009:adverse effects; D015496:CD4-Positive T-Lymphocytes / Q000187:drug effects / Q000276:immunology; D016022:Case-Control Studies; D002478:Cells, Cultured; D016207:Cytokines / Q000097:blood*; D005260:Female; D005938:Glucocorticoids / Q000627:therapeutic use; D015658:HIV Infections / Q000097:blood / Q000188:drug therapy / Q000276:immunology*; D006801:Humans; D054019:Immune Reconstitution Inflammatory Syndrome / Q000097:blood / Q000139:chemically induced / Q000276:immunology*; D007963:Leukocytes, Mononuclear / Q000187:drug effects / Q000276:immunology; D008297:Male; D008875:Middle Aged; D009169:Mycobacterium tuberculosis / Q000276:immunology; D011241:Prednisone / Q000627:therapeutic use; D014376:Tuberculosis / Q000097:blood / Q000276:immunology*; D055815:Young Adult
D016207:Cytokines; D005938:Glucocorticoids; D011241:Prednisone
Afr Health Sci. 2008 Sep;8(3):190-5
19357749
N Engl J Med. 2006 Sep 7;355(10):1018-28
16908486
Curr HIV/AIDS Rep. 2009 Aug;6(3):162-71
19589302
Clin Infect Dis. 2009 May 15;48(10):1429-32
19364287
Am J Respir Crit Care Med. 2009 Oct 1;180(7):674-83
19628776
AIDS. 2009 Nov 27;23(18):2467-71
19898217
Enferm Infecc Microbiol Clin. 2001 Feb;19(2):88-90
11333583
Science. 1997 Jul 4;277(5322):112-6
9204894
Lancet Infect Dis. 2008 Aug;8(8):516-23
18652998
J Infect Dis. 2001 Oct 15;184(8):1073-7
11574925
Nat Immunol. 2007 Apr;8(4):369-77
17351619
PLoS One. 2009;4(2):e4520
19229341
Sex Transm Infect. 2003 Aug;79(4):337-8
12902592
Clin Infect Dis. 2009 Jun 1;48(11):e96-107
19405867
Lancet. 2002 Jun 15;359(9323):2059-64
12086758
Clin Infect Dis. 2009 Mar 1;48(5):667-76
19191655
J Immunol. 1999 Feb 15;162(4):2347-52
9973514
Lancet Infect Dis. 2009 May;9(5):281-90
19393958
AIDS. 2007 Apr 23;21(7):882-4
17415049
Thorax. 2004 Aug;59(8):704-7
15282393
J Infect Dis. 1998 Aug;178(2):580-4
9697749
Semin Respir Crit Care Med. 2006 Aug;27(4):350-64
16909369
J Infect. 2006 Dec;53(6):357-63
16487593
Lancet. 2007 Dec 15;370(9604):2030-43
17719083
J Infect Dis. 2009 Dec 1;200(11):1736-45
19874177
AIDS. 2009 Jan 2;23(1):143-5
19050399
AIDS. 1992 Nov;6(11):1293-7
1472334
Southeast Asian J Trop Med Public Health. 2007 Nov;38(6):1053-60
18613546
Injury. 2007 Dec;38(12):1336-45
18048040
AIDS. 2006 Jan 9;20(2):F1-7
16511406
AIDS. 2005 Mar 4;19(4):399-406
15750393
Clin Infect Dis. 2007 Dec 1;45(11):1518-21
17990236
AIDS Res Hum Retroviruses. 2002 Sep 1;18(13):969-75
12230939
Lancet Infect Dis. 2006 Jan;6(1):2-3; author reply 4-5
16377524
N Engl J Med. 2010 Feb 25;362(8):697-706
20181971
Nat Med. 2006 Oct;12(10):1203-7
16964257
J Immunol. 2008 Feb 1;180(3):1962-70
18209095
Am J Respir Crit Care Med. 2008 Nov 15;178(10):1083-9
18755923
HIV Med. 2002 Jan;3(1):21-7
12059947
Eur J Immunol. 2009 Feb;39(2):391-403
19180462
Clin Vaccine Immunol. 2007 Jul;14(7):847-54
17522328
Clin Infect Dis. 2004 Dec 1;39(11):1709-12
15578375
AIDS. 2005 Dec 2;19(18):2109-16
16284460
Blood. 1990 Feb 15;75(4):1011-6
2405918
Int J Tuberc Lung Dis. 2007 Dec;11(12):1282-9
18229435
Tuberculosis (Edinb). 2008 Sep;88(5):453-61
18495539
AIDS. 2002 Oct 18;16(15):2043-7
12370503
N Engl J Med. 2001 Oct 11;345(15):1098-104
11596589
AIDS. 2007 Jan 30;21(3):335-41
17255740
Am J Respir Crit Care Med. 1998 Jul;158(1):157-61
9655723
PLoS One. 2008 Jul 02;3(7):e2535
18596971
HIV Med. 2008 May;9(5):307-16
18400078
Antivir Ther. 2005;10(3):417-22
15918332
Braz J Infect Dis. 2007 Oct;11(5):462-5
17962870
BMC Pulm Med. 2009 May 16;9:21
19445695
Clin Infect Dis. 2008 Nov 15;47(10):e83-5
18840076
AIDS. 2010 Jan 2;24(1):103-8
19926965
J Immunol. 2009 Sep 15;183(6):3915-23
19726768
Am J Respir Crit Care Med. 2008 Apr 1;177(7):680-5
18202347
J Clin Immunol. 2004 Nov;24(6):647-52
15622449
Mol Microbiol. 2001 Feb;39(3):813-21
11169120
Nat Immunol. 2005 Nov;6(11):1123-32
16200070